EP Patent

EP2524912A1 — Amine derivatives

Assigned to Bionomics Ltd · Expires 2012-11-21 · 13y expired

What this patent protects

The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.

USPTO Abstract

The present invention relates to Kv1.3 potassium channel blockers of Formula (I) and their use in the treatment of autoimmune and inflammatory diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP2524912A1
Jurisdiction
EP
Classification
—
Expires
2012-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Bionomics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.